Loading…

Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity

Carbocyclic analogs of several naturally occurring and biologically active purine nucleosides have been synthesized (1–4). In these analogs a methylene group occupies the position of the ring oxygen atom of the ribo- or deoxyribofuranosides. Because of the presence of a stable carbon-nitrogen bond a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical sciences 1973-05, Vol.62 (5), p.858-859
Main Authors: Fulmer Shealy, Y., Clayton, Joe D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Carbocyclic analogs of several naturally occurring and biologically active purine nucleosides have been synthesized (1–4). In these analogs a methylene group occupies the position of the ring oxygen atom of the ribo- or deoxyribofuranosides. Because of the presence of a stable carbon-nitrogen bond at position 9 of the purine moiety, these analogs are not subject to cleavage by enzymes that remove or transfer the ribofuranosyl moiety of the nucleosides or nucleotides. Biochemical studies (5–7) have shown that the racemic analog (III) of adenosine can serve either as a substrate for or as an inhibitor of some of the enzymes involved in purine nucleotide metabolism, one of the more interesting findings being the inhibition of guanylic acid kinase by the phosphate (7). The antibiotic aristeromycin (8). the optically active form (9, 10) of the adenosine analog, inhibits certain plant pathogens (8, 11). Several racemic carbocyclic analogs of purine nucleosides are cytotoxic to neoplastic cells growing in culture (4). In this communication, antileukemic activity in vivo by a carbocyclic analog, the 8-azaadenosine analog (II), is reported.
ISSN:0022-3549
1520-6017
DOI:10.1002/jps.2600620547